Skip to content

LeMaitre Vascular

US · LMAT #2839 by market cap Listed 1970
79.31 +0.26 +0.33%
Live - 5344 symbols - heartbeat 451s ago · 2026-10-08 07:00
Pre-market 78.93 -0.48%
After-hours 79.31 0.00%
Market cap
1.81B
P/B
4.32
EPS
2.52
Reader sentiment Are you bullish or bearish on LMAT?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Roth MKM Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $108
    Market Newswire · 2025/11/7
  • Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/10/1
  • Rating change
    Roth MKM Initiates LeMaitre Vascular(LMAT.US) With Buy Rating, Announces Target Price $108
    Market Newswire · 2025/11/5
  • Rating change
    Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/2/20
  • Rating change
    A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $94 to $118
    Market Newswire · 2026/2/26
  • Rating change
    A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $95 to $120
    Market Newswire · 2025/11/8
  • Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/8/5
  • Rating change
    A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124
    Market Newswire · 2026/2/27
  • Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Announces Target Price $95
    Market Newswire · 2026/8/6
  • Barrington Downgrades LeMaitre Vascular(LMAT.US) to Hold Rating
    Market Newswire · 2026/8/5
  • Rating change
    Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $127
    Market Newswire · 2026/5/6
  • KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
    Market Newswire · 2026/8/5
  • Rating change
    Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/5/6
  • Rating change
    Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $97
    Market Newswire · 2025/8/27
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT)
    TipRanks · 2025/11/7
  • Rating change
    A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $120 to $135
    Market Newswire · 2026/5/7
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Lemaitre Vascular (LMAT) and Gilead Sciences (GILD)
    TipRanks · 2026/6/3
  • Rating change
    Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/6/3
  • Rating change
    Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Cuts Target Price to $93
    Market Newswire · 2025/11/26
  • Rating change
    Wells Fargo Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $93
    Market Newswire · 2025/12/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:00:15 · For reference only, not investment advice and not tailored to your situation.